TSXV:VER.H - Post by User
Post by
herbaciouson Mar 22, 2011 6:38am
279 Views
Post# 18320250
RE RE I AM OUT OF HERE
RE RE I AM OUT OF HEREIF YOU BOUGHT AT 70, BUY AS MUCH AS YOU CAN HERE.
ZACKS EQUITY RESEARCH HAS A TARGET OF$2.10 IN 6 MONTHS, WHICH WAS PUBLISHED FEB 4TH2011
LISTED AS OUT PERFORM
Based on preliminary trial data, high throughout and other advantages, Verisante's Aura could eventually become the new gold stanard for skin cancer diagnosis.
looking for Aura to launch in Europre/ Canada / Australia by early 2012 and in the U.S. in late 2013.
the size and high incidence of skin cancer in these markets, combined with Verisantes razor/razor blade business model and low cost base means revinue and earnings could ramp up very quickly.
full analyses of a large clinical trial is expected by may 2011, at which time the probability of approval and launch time will be made more clear.
accumilate it not sell it!
do your own due diligence
herb